美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Clinuvel Pharmaceuticals Ltd.

7.42

-0.3800-4.87%

成交量：2.67萬

成交額：21.00萬

市值：3.74億

市盈率：17.97

高：8.20

開：8.00

低：7.42

收：7.80

52周最高：9.00

52周最低：5.98

股本：5,042.79萬

流通股本：4,387.83萬

量比：3.01

換手率：0.06%

股息：0.03

股息率：0.46%

每股收益(TTM):0.4130

每股收益(LYR):0.4707

淨資產收益率：13.96%

總資產收益率：10.62%

市淨率：2.10

市盈率(LYR):15.76

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Clinuvel Pharmaceuticals Ltd.

交易所：

NASDAQ

成立時間：

1999

員工人數：

16

公司地址：

535 Bourke Street,Level 22,Melbourne,Victoria,Australia

官網：

http://www.clinuvel.com

郵編：

3000

電話：

傳真：

61 3 9660 4909

簡介：

Clinuvel Pharmaceuticals Limited是一家於1999年根據澳大利亞法律註冊成立的股份有限公司。該公司是一家全球性專業製藥集團，專註於為患有遺傳性、代謝性、全身性和危及生命的急性疾病的患者開發治療方法並將其商業化，以及為專門人群開發醫療保健解決方案，業務遍及歐洲、新加坡和美國。

董事

名稱

職位

Guy van Dievoet

Non-Executive Director

Jeffrey Rosenfeld

Chair of the Board and Non-Executive Director

Karen Agersborg

Non-Executive Director

Matthew Pringle

Non-Executive Director

Pearl Grimes

Non-Executive Director

Susan Smith

Non-Executive Director

股東

名稱

職位

Philippe Wolgen

Chief Executive Officer and Managing Director

Lachlan Hay

Chief Operating Officer

Peter Vaughan

Chief Financial Officer

Dennis Wright

Chief Scientific Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/CUVL/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUVL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUVL\",,,,,undefined,":{"symbol":"CUVL","market":"US","secType":"STK","nameCN":"Clinuvel Pharmaceuticals Ltd.","latestPrice":7.42,"timestamp":1787601600000,"preClose":7.8,"halted":0,"volume":26659,"delay":0,"changeRate":-0.048717948717948704,"floatShares":43878300,"shares":50427898,"eps":0.413,"marketStatus":"盤前交易","change":-0.38,"latestTime":"08-25 05:00:18 EDT","open":8,"high":8.2,"low":7.42,"amount":210019.02349969998,"amplitude":0.1,"askPrice":8.89,"askSize":100,"bidPrice":7.02,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.413,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"adrRate":1,"exchange":"NASDAQ","adjPreClose":7.42,"dividendRate":0.004609,"postHourTrading":{"tag":"盘后","latestPrice":7.42,"preClose":7.42,"latestTime":"19:30 EDT","volume":18,"amount":139.573,"timestamp":1787614203065,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.011227554919585},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUVL\",,,,,undefined,":{"symbol":"CUVL","floatShares":43878300,"roa":"10.62%","roe":"13.96%","lyrEps":0.470726,"volumeRatio":3.011227554919585,"shares":50427898,"dividePrice":0.0342,"high":8.2,"amplitude":0.1,"preClose":7.8,"low":7.42,"week52Low":5.98,"pbRate":"2.10","psRate":"5.44","week52High":9,"institutionHeld":0,"latestPrice":7.42,"committee":0.666667,"eps":0.413,"divideRate":0.004609,"volume":26659,"delay":0,"ttmEps":0.413,"open":8,"prevYearClose":8.48,"prevWeekClose":7.8,"prevMonthClose":6.49,"prevQuarterClose":7.3,"fiveDayClose":6.875,"twentyDayClose":7.01,"sixtyDayClose":6.56,"earningDate":1787673600000,"earningTime":"盘前","dividendPayoutRate":0.06321640227534814,"dividendFrequency":"A","dividendGrowthYears":0,"fiveYearAvgDividendRate":0.004402647058823529},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUVL\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"CUVL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787731200000,"name":null,"time":"盤前","dateTimestamp":1787716800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUVL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CUVL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1772078400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CUVL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CUVL","date":"2026-08-24","current":17.966102,"percent":0.833333,"low":14.040514,"twenty":14.508531,"median":15.047836,"eighty":15.893986,"high":16.876512,"avg":15.153217,"sd":0.721846,"marketCap":372284073.97},"quantilePoints":[{"date":"2026-07-24","current":15.59024,"twenty":15.398074,"median":15.574742,"eighty":15.64603,"marketCap":353645627.74},{"date":"2026-07-31","current":14.040514,"twenty":14.675902,"median":15.311289,"eighty":15.580941,"marketCap":320255681.34},{"date":"2026-08-07","current":14.62941,"twenty":14.316365,"median":14.745639,"eighty":15.481759,"marketCap":334861674.87},{"date":"2026-08-14","current":14.79988,"twenty":14.434144,"median":14.861869,"eighty":15.354681,"marketCap":340007360.21},{"date":"2026-08-21","current":16.148141,"twenty":14.496133,"median":14.978098,"eighty":15.70182,"marketCap":374125095.76},{"date":"2026-08-24","current":15.993168,"twenty":14.508531,"median":15.047836,"eighty":15.893986,"marketCap":372284073.97}],"updateTime":1787648418065},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4909","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":0.0793},{"period":"1month","weight":0.0676},{"period":"3month","weight":0.1236},{"period":"6month","weight":-0.0995},{"period":"1year","weight":-0.1033},{"period":"ytd","weight":-0.125}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1014},{"period":"1year","weight":0.1831},{"period":"ytd","weight":0.1196}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Clinuvel Pharmaceuticals Limited是一家於1999年根據澳大利亞法律註冊成立的股份有限公司。該公司是一家全球性專業製藥集團，專註於為患有遺傳性、代謝性、全身性和危及生命的急性疾病的患者開發治療方法並將其商業化，以及為專門人群開發醫療保健解決方案，業務遍及歐洲、新加坡和美國。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.016564},{"month":2,"riseRate":0.25,"avgChangeRate":-0.088904},{"month":3,"riseRate":0.375,"avgChangeRate":0.036975},{"month":4,"riseRate":0.625,"avgChangeRate":0.007121},{"month":5,"riseRate":0.555556,"avgChangeRate":0.057074},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.013615},{"month":7,"riseRate":0.555556,"avgChangeRate":0.025547},{"month":8,"riseRate":0.666667,"avgChangeRate":0.044239},{"month":9,"riseRate":0.5,"avgChangeRate":0.03444},{"month":10,"riseRate":0.5,"avgChangeRate":-0.018995},{"month":11,"riseRate":0.5,"avgChangeRate":-0.022089},{"month":12,"riseRate":0.625,"avgChangeRate":0.039793}],"exchange":"NASDAQ","name":"Clinuvel Pharmaceuticals Ltd.","nameEN":"Clinuvel Pharmaceuticals Ltd.","securityTypeName":"存托凭证","adrRate":"1:1"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CUVL\",market:\"US\",,,undefined,":{"directors":[{"name":"Guy van Dievoet","position":"Non-Executive Director"},{"name":"Jeffrey Rosenfeld","position":"Chair of the Board and Non-Executive Director"},{"name":"Karen Agersborg","position":"Non-Executive Director"},{"name":"Matthew Pringle","position":"Non-Executive Director"},{"name":"Pearl Grimes","position":"Non-Executive Director"},{"name":"Susan Smith","position":"Non-Executive Director"}],"executives":[{"name":"Philippe Wolgen","position":"Chief Executive Officer and Managing Director"},{"name":"Lachlan Hay","position":"Chief Operating Officer"},{"name":"Peter Vaughan","position":"Chief Financial Officer"},{"name":"Dennis Wright","position":"Chief Scientific Officer"}]}}}